The content provided on this website is for informational or educational purposes only and is not a substitute for medical advice or treatment for any medical conditions. Consult a physician regarding the applicability of any information and recommendations with respect to your health condition.

Reproduction or republication is strictly prohibited without prior written permission.

60 Resveratrol Health Benefits

Reported by Online Medical Researchers

Home

Resveratrol

Resveratrol and Leukemia

As a form of cancer that strikes the white blood cells, Leukemia is fairly common especially among children. Resveratrol’s promise as an anti-carcinogenic may be used to prevent and cure this type of cancer. The substance is commonly found in red wines that have figured in the healthier and longer lives of the French people taking high fat diets that have been the cause of heart diseases in Americans.

In studies after studies around the world, its anti-cancer properties has been revealed and independently confirmed in lab experiments using mice and other animals. It main promise lies in its apoptotic quality to induce death of tumor cells without affecting adjacent healthy cells. Colon, breast, pancreatic and brain cancers have been shown to respond with Resveratrol treatment in lab rats.

Research Findings: Resveratrol vs Luekemia

A couple of recent studies have shown that Resveratrol has curative benefits in treating leukemia using any of its known anti-carcinogenic properties. One experiment on chronic myelogenous leukemia (CLM) K562 tumor cells showed that Resveratrol induced apoptosis on these cells in a time-bound manner.

In addition, an enzyme that makes leukemia resistant to chemotherapy called Ksp70 in the, RNA cellular level is significantly suppressed by Resveratrol making the cancer sensitive and responsive to drugs in chemotherapy.

In another study conducted by Indian scientists in 2008 and published in the Cancer Science Journal dated June of 2008, Resveratrol had been shown to have chemopreventive property which inhibits three major states in carcinogenesis – initiation, promotion and progression which accounts for its success in mediated cell death in leukemia cells, this time in a dose-related manner.

Farther independent studies may be needed to corroborate these exciting results that could pave the way for more clinical studies on human patients. This can turn the promise into a real pharmacological treatment to leukemia with FDA approval.

By Admin, Resveratrols.org

Comment/Publish Your Articles Here